Belen Garijo's potential return to Sanofi is anticipated to be challenging. Bloomberg posted on X, highlighting that while Garijo's return to her former employer might feel like a homecoming, the path ahead is fraught with difficulties. Garijo, who previously held a senior position at Sanofi, is expected to face significant hurdles in navigating the company's current landscape. The pharmaceutical industry is undergoing rapid changes, and Sanofi is no exception, with evolving market dynamics and competitive pressures. Garijo's leadership will be crucial in steering the company through these challenges and ensuring its continued success in a highly competitive environment.